Form 8-K - Current report:
SEC Accession No. 0001213900-24-052116
Filing Date
2024-06-12
Accepted
2024-06-12 16:35:45
Documents
13
Period of Report
2024-06-09
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea020777101-8k_aditxt.htm   iXBRL 8-K 28006
  Complete submission text file 0001213900-24-052116.txt   203558

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20240609.xsd EX-101.SCH 3018
3 XBRL LABEL FILE adtx-20240609_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20240609_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT ea020777101-8k_aditxt_htm.xml XML 3779
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241038874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)